Nevertheless, new approaches of peptide-mediated targeting to achieve cell-specific modulation of iGluRs can make use of high-affinity drugs as well, as it was recently demonstrated by targeting high-affinity NMDAR channel blocker MK-801 to GLP-1 receptor-expressing brain regions for safe and effective obesity treatment99. This evidence concerns the gene GLP1R and obesity disorder.